CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in EYPT — EyePoint, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in EYPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,260,865
+$1,009,680 QoQ
Shares Held
647,613
+1.2% QoQ
Ownership
0.751%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 188 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. EYPT ranks #107 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in EYPT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,260,865 | 647,613 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,251,185 | 640,123 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,849,282 | 648,565 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,571,735 | 531,723 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,786,751 | 189,878 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,036,000 | 191,144 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,424,179 | 191,165 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,140,676 | 142,763 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,172,725 | 134,796 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,063,899 | 99,850 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,812,055 | 78,410 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $571,668 | 71,548 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $622,467 | 71,548 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $209,569 | 71,282 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $249,487 | 71,282 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $544,382 | 68,822 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $543,195 | 69,021 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $817,561 | 67,289 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $663,481 | 54,206 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $544,684 | 52,273 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $469,934 | 52,273 | Shares | Sole | 2021-08-16 | |
| 2020-09-30 | $7,592 | 14,600 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,096 | 14,600 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $145,591 | 142,737 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||